(Q53559924)

15 May 2018

title

Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. (English)

1 reference

15 May 2018

1 reference

1 reference

Clare L Hibbert

1

1 reference

15 May 2018

Pedro A Piedra

2

1 reference

15 May 2018

Kimmie K McLaurin

3

1 reference

15 May 2018

Timo Vesikari

4

1 reference

15 May 2018

Josephine Mauskopf

5

1 reference

15 May 2018

Parthiv J Mahadevia

6

1 reference

15 May 2018

language of work or name

English

0 references

publication date

25 September 2007

1 reference

15 May 2018

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

15 May 2018

volume

25

1 reference

15 May 2018

issue

47

1 reference

15 May 2018

page(s)

8010-8020

1 reference

15 May 2018

Health impact of influenza in the United States.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

The underrecognized burden of influenza in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Estimating influenza hospitalizations among children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Influenza-associated hospitalizations in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Influenza and the rates of hospitalization for respiratory disease among infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Population-wide benefits of routine vaccination of children against influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

An influenza simulation model for immunization studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

The Japanese experience with vaccinating schoolchildren against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Community interventions and the epidemic prevention potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Effectiveness of school-based influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Potential cost savings attributable to influenza vaccination of school-aged children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Economic impact of influenza vaccination in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

An economic analysis of annual influenza vaccination of children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Health benefits, risks, and cost-effectiveness of influenza vaccination of children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Impact of influenza infection in healthy children examined as outpatients and their families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

A pharmacoeconomic model for the treatment of influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Live attenuated versus inactivated influenza vaccine in infants and young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Potential burden of universal influenza vaccination of young children on visits to primary care practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Burden of influenza in children in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

The cost of giving childhood vaccinations: differences among provider types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

A study of influenza and influenza-related complications among children in a large US health insurance plan database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Direct medical cost of influenza-related hospitalizations in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Cost-effectiveness of influenza vaccination of healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

Cost-Effectiveness of Adjuvanted Influenza Vaccination of Healthy Children 6 to 60 Months of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.018

10.1016/J.VACCINE.2007.09.018

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018